2467411-25-0
Chemical Structure
Fiztasovimab
Synonym(s): NPC-21; EV2038
- CAS. Nr.: 2467411-25-0
- Formula:N/A
- Molecular Weight:(144.49 kDa)
IUPAC Name: methyl 4-bromo-5-sulfamoylthiophene-2-carboxylate
SMILES: [Fiztasovimab]
Biological Activity: Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fiztasovimab | 96.49% | Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMV envelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords